SCM
CNTB

Sterling Capital Management’s Connect Biopharma Holdings CNTB Stock Holding History

Sterling Capital Management’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$357 Buy
+150
New +$364 ﹤0.01% 3240

Other funds holding CNTB

KWM
Koa Wealth Management Encinitas, California $147M AUM 18.41% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Sterling Capital Management's CNTB Position: Q2 2026 in Review

Sterling Capital Management opened a new position in Connect Biopharma Holdings (CNTB) in Q2 2026: 150 shares worth $357. The stake represents ﹤0.01% of the portfolio and ranks #3240 among its holdings.

6 funds tracked by Wall St. Rank hold CNTB as of Q2 2026.

  • Sterling Capital Management held 150 shares of Connect Biopharma Holdings worth $357 as of Q2 2026.
  • Connect Biopharma Holdings was a new Sterling Capital Management position in Q2 2026.
  • Connect Biopharma Holdings made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #3240 holding.
  • 6 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.